<  Back to the Polytechnique Montréal portal

Tau levels in platelets isolated from Huntington's disease patients serve as a biomarker of disease severity

Melanie Alpaugh, Juan Lantero Rodrı́guez, Andréa Lessa Benedet, Uriel Manseau-Pérez, Molly E. Boutin, Massimo Maiuri, Hélèna L. Denis, Maria Masnata, Shaline V. Fazal, Sylvain Chouinard, Pedro Rosa-Neto, Roger A. Barker, Kaj Blennow, Henrik Zetterberg, Richard Labib and Francesca Cicchetti

Article (2025)

An external link is available for this item
Department: Department of Mathematics and Industrial Engineering
PolyPublie URL: https://publications.polymtl.ca/63295/
Journal Title: Journal of Neurology (vol. 272, no. 3)
Publisher: Springer Science+Business Media
DOI: 10.1007/s00415-025-12966-9
Official URL: https://doi.org/10.1007/s00415-025-12966-9
Date Deposited: 10 Mar 2025 13:50
Last Modified: 08 Apr 2025 07:32
Cite in APA 7: Alpaugh, M., Rodrı́guez, J. L., Benedet, A. L., Manseau-Pérez, U., Boutin, M. E., Maiuri, M., Denis, H. L., Masnata, M., Fazal, S. V., Chouinard, S., Rosa-Neto, P., Barker, R. A., Blennow, K., Zetterberg, H., Labib, R., & Cicchetti, F. (2025). Tau levels in platelets isolated from Huntington's disease patients serve as a biomarker of disease severity. Journal of Neurology, 272(3), 11 pages. https://doi.org/10.1007/s00415-025-12966-9

Statistics

Dimensions

Repository Staff Only

View Item View Item